Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Vuity (AGN-190584) on Night-driving Performance
NCT04837482Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by AbbVie Inc.. Started May 2021; status: completed.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT04837482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04837482.